Related Experiment Video
Updated: Aug 5, 2026
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Drawing conclusions: blood culture yield across clinical scenarios in hematologic malignancy
Jessica Seidelman1, Patrick Tam2, Julia Messina3
1Infectious Diseases, Duke University Hospital, Durham, USA.
Patients with hematologic malignancies are excluded from most blood culture stewardship algorithms. We evaluated blood culture collection patterns and bloodstream infection incidence across clinical scenarios in this population. Blood culture yield varied substantially by indication, identifying high-yield scenarios and opportunities to refine diagnostic stewardship while preserving patient safety.
Patients with hematologic malignancies are excluded from most blood culture stewardship algorithms. We evaluated blood culture collection patterns and bloodstream infection incidence across clinical scenarios in this population. Blood culture yield varied substantially by indication, identifying high-yield scenarios and opportunities to refine diagnostic stewardship while preserving patient safety.